Mixed histiocytic disorders: Nature versus nurture?

Br J Haematol. 2024 Jul;205(1):20-21. doi: 10.1111/bjh.19511. Epub 2024 May 19.

Abstract

Histiocytic diseases arise from MAPK mutations in myeloid progenitors. Depending on whether the progenitor follows a dendritic cell or macrophage/monocyte lineage the final histology results in Langerhans cell histiocytosis, Rosai-Dorfman disease or Erdheim-Chester disease. Commentary on: Friedman et al. Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy. Br J Haematol 2024;205:127-137.

Keywords: MAPK mutations; histiocytic diseases; myeloid progenitors.

MeSH terms

  • Erdheim-Chester Disease / diagnosis
  • Erdheim-Chester Disease / genetics
  • Erdheim-Chester Disease / pathology
  • Histiocytosis, Langerhans-Cell / diagnosis
  • Histiocytosis, Langerhans-Cell / genetics
  • Histiocytosis, Langerhans-Cell / pathology
  • Histiocytosis, Sinus / diagnosis
  • Histiocytosis, Sinus / genetics
  • Histiocytosis, Sinus / pathology
  • Humans
  • Mutation*